Article Details
Retrieved on: 2022-12-28 08:14:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
UK: AstraZeneca has announced that the company's immunotherapies Imfinzi (durvalumab) and Imjudo (tremelimumab) have been approved in Japan for ...
Article found on: medicaldialogues.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here